Side-by-side comparison of AI visibility scores, market position, and capabilities
Slingshot AI raised $93M (a16z) for its Ash therapy chatbot with 50K beta users; withdrew from UK over medical device concerns while expanding US CBT-informed AI mental health access.
Slingshot AI is a mental health technology company developing AI-powered therapy and emotional support tools designed to expand access to mental health care. Backed by Andreessen Horowitz (a16z), Slingshot has built Ash, a conversational AI therapy chatbot that provides CBT-informed and evidence-based support to users between professional therapy sessions or as a standalone resource for people who cannot access or afford traditional therapy. The company was founded on the premise that the global mental health crisis — characterized by a severe shortage of therapists relative to need — requires AI-enabled solutions to close the access gap.\n\nAsh is designed to conduct structured therapeutic conversations, guide users through mental health exercises, track mood and symptom patterns over time, and provide crisis resources when needed. The platform is built with clinical input and aims to function at the boundary between a mental wellness app and a clinical-grade tool, offering more depth than meditation apps while being accessible without a prescription or insurance. Slingshot has enrolled 50,000+ beta users who have engaged with Ash's conversational therapy features across depression, anxiety, and stress-related concerns.\n\nSlingshot has raised $93M in total funding, backed by a16z and other investors, reflecting strong venture conviction in the mental health AI space despite a complex regulatory environment. The company made a notable decision to withdraw from the UK market in January 2026 over concerns about medical device regulatory requirements — the UK's MHRA was signaling that AI therapy tools would require medical device classification, raising the compliance burden significantly. This withdrawal highlights the tension between the consumer mental health app model and the regulatory frameworks emerging around AI clinical tools, a challenge Slingshot and the broader mental health AI category are actively navigating.
Indianapolis BCBS managed care (NYSE: ELV) ~$175B FY2024 revenue; Anthem renamed 2022, BCBS exclusive in 14 states, Carelon health services, Medicaid/MA medical cost pressure competing with UnitedHealth and Cigna.
Elevance Health, Inc. (formerly Anthem, Inc.) is an Indianapolis, Indiana-based managed care and health services company — publicly traded on the New York Stock Exchange (NYSE: ELV) as an S&P 500 Health Care component — providing health insurance plans under the Blue Cross Blue Shield brand in 14 states (Indiana, Georgia, California, Colorado, Connecticut, Kentucky, Maine, Missouri, Nevada, New Hampshire, New York, Ohio, Virginia, Wisconsin), Medicare Advantage, Medicaid managed care, and commercial employer-sponsored health plans through Carelon (pharmacy and behavioral health services — formerly IngenioRx) to approximately 47 million medical members through approximately 100,000 employees. In fiscal year 2024, Elevance Health reported revenues of approximately $175 billion (predominantly premium revenues from employer-sponsored and government-program health plan members), with operating income under pressure from medical cost increases in the Medicaid segment (post-COVID health utilization normalization causing medical costs to exceed Medicaid actuarial pricing expectations set during the pandemic period of reduced care utilization). CEO Gail Boudreaux has executed the company's transformation from Anthem to Elevance Health (rebranded June 2022) — reflecting the broadened value proposition beyond health insurance into health services: Carelon Services (behavioral health, pharmacy benefit management, utilization management, home health services for both Elevance and external health plan clients) represents the strategy of building a health services ecosystem that retains value within the Elevance enterprise rather than paying external PBMs, behavioral health managers, and care management vendors.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.